| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |